An expanding retail marketplace means that there are more opportunities for health plans to develop innovative strategies to reach consumers that are entering the market space for the first time. It is essential for health plans to not only engage these consumers but also to assist them in making good healthcare decisions.
An expanding retail marketplace means that there are more opportunities for health plans to develop innovative strategies to reach consumers that are entering the market space for the first time. It is essential for health plans to not only engage these consumers but also to assist them in making good healthcare decisions. On Tuesday, Juan-Pierre Stephan, senior executive, Health CRM, Accenture, spoke about approaches and barriers to effective patient engagement.
The data-heavy presentation began with a number of statistics, including the following:
Accenture initiated studies to determine what exactly all of these statistics could mean for the marketplace. The results provided 4 insights that are key to the success of health insurers:
Part of the problem insurers now face in this evolving landscape is the fact that consumers often define themselves into segments differently than their insurers do. Many insurers use antiquated techniques to segment their populations, and this needs to change in order to succeed in a much different and constantly changing landscape. Unfortunately, Mr. Stephan said, change needs to come from the top. Barriers like fragmented project implementations and a lack of enterprise sponsorship can deter organizations from enacting change that could lead to success in a new marketplace. Additionally, said Mr. Stephan, the influence of employee engagement as a catalyst for change is vastly undervalued at many organizations. However, it is not too late to enact company-wide transformations. If organizations are able to break down the silos, identify core competencies, and align incentives (both internally and externally), they stand to enjoy early and continued success in a highly competitive market.
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More